I don't know Trding , I really don't understand Gilead ,
Very curious what will happen to their HIV income in a year or two.......

More talk now about NASH everyplace in medicine ,

Talks that HAART drugs might produce NASH and the worse is Tenofovir...

Gilead is so proud from their new medicine ...
So far making good money,

But lets look their best selling products ...

Truvada for PrEP older drug ...Emcitricitabine and Tenofovir...

They changed now dose of Tenofovir and came out with Descovy, but still has Tenofovir ...

The best seller is now ,

Biktarvy , 3 drugs in one :

-Bicteprevir
-Emtricitabine
-Tenofovir

So in medicine generally much more talks now about NASH , Gilead has nothing good without Tenofovir , and Tenofovir is the most dangerous to liver from all those cocktails in possibilities of producing NASH .

All together Tenofovir is included in about 70% of HAART.

I already can see some good advertising for Leronlimab ....

" Our medicine is not including Tenofovir which can produce NASH "

Just lets be approve , Gilead is in a very big problem in 1-2 years ..


IMO as always.